Currently out of the existing stock ratings of Mohan Naidu, 64 are a BUY (100%).

Mohan Naidu

Work Performance Price Targets & Ratings Chart

Analyst Mohan Naidu, carries an average stock price target met ratio of 74.77% that have a potential upside of 28.63% achieved within 516 days.

Mohan Naidu’s has documented 141 price targets and ratings displayed on 12 stocks. The coverage was on Healthcare, Technology sectors.

Most recent stock forecast was given on EVH, Evolent Health at 12-Nov-2025.

Wall Street Analyst Mohan Naidu

Analyst best performing recommendations are on TRHC (TABULA RASA HEALTHCARE).
The best stock recommendation documented was for TDOC (TELADOC) at 1/24/2025. The price target of $12 was fulfilled within 14 days with a profit of $1.91 (18.93%) receiving and performance score of 13.52.

Average potential price target upside

of $33.86 (27.51%) on ATHN (ATHENAHEALTH).
of $14.81 (22.82%) on CERN (CERNER CORP).
of $14.69 (22.4%) on TDOC (TELADOC).

HQY HealthEquity OMCL Omnicell TDOC Teladoc TVTY Tivity Health VCRA Vocera Communications ATHN athenahealth CERN Cerner Corp CVS CVS Health Corp HMSY HMS Holdings Corp EVH Evolent Health PINC Premier TRHC Tabula Rasa HealthCare

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

David Roman (GOLDMAN SACHS)